Next Article in Journal
Scientia Pharmaceutica, Autorenhinweise 2012
Previous Article in Journal
Osmotically Regulated Two-Compartment Asymmetric Membrane Capsules for Simultaneous Controlled Release of Anti-Hypertensive Drugs
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods

by
Sagar Suman PANDA
*,
Bera V. V. RAVI KUMAR
,
Rabisankar DASH
and
Ganeswar MOHANTA
Department of Pharmaceutical Analysis and Quality Assurance, Roland Institute of Pharmaceutical Sciences, Khodasingi, 760010, Berhampur (Odisha), India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(4), 1029-1042; https://doi.org/10.3797/scipharm.1306-07
Submission received: 11 June 2013 / Accepted: 31 July 2013 / Published: 31 July 2013

Abstract

An ultra-fast liquid chromatographic method and two UV spectroscopic methods were developed for the determination of cephalexin monohydrate in pharmaceutical dosage forms. Isocratic separation was performed on an Enable C18G column (250 mm × 4.6 mm i.d., 5 μm) using methanol:0.01 M TBAHS (50:50, v/v) as the mobile phase at a flow rate of 1.0 ml/min. The PDA detection wavelength was set at 254 nm. The UV spectroscopic method was performed at 261 nm and at 256-266 nm for the AUC method using a phosphate buffer (pH=5.5). The linearity was observed over a concentration range of 1.0–120 μg/ml for UFLC and both of the UV spectroscopic methods (correlation coefficient=0.999). The developed methods were validated according to ICH guidelines. The relative standard deviation values for the intraday and interday precision studies were < 2%, and the accuracy was > 99% for all of the three methods. The developed methods were used successfully for the determination of cephalexin in dry syrup formulation.
Keywords: AUC; Cefalexin; Spectroscopy; UFLC-PDA; Chromatography AUC; Cefalexin; Spectroscopy; UFLC-PDA; Chromatography

Share and Cite

MDPI and ACS Style

PANDA, S.S.; KUMAR, B.V.V.R.; DASH, R.; MOHANTA, G. Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods. Sci. Pharm. 2013, 81, 1029-1042. https://doi.org/10.3797/scipharm.1306-07

AMA Style

PANDA SS, KUMAR BVVR, DASH R, MOHANTA G. Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods. Scientia Pharmaceutica. 2013; 81(4):1029-1042. https://doi.org/10.3797/scipharm.1306-07

Chicago/Turabian Style

PANDA, Sagar Suman, Bera V. V. RAVI KUMAR, Rabisankar DASH, and Ganeswar MOHANTA. 2013. "Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods" Scientia Pharmaceutica 81, no. 4: 1029-1042. https://doi.org/10.3797/scipharm.1306-07

Article Metrics

Back to TopTop